| Discipline name | Position | Best Scientists | Publications | D-Index |
|---|---|---|---|---|
| Medicine | 1456 | 64 | 65 | 17 |
The objective of Therapeutic advances in hematology is to combine knowledge in the areas of Internal medicine, Oncology, Immunology, Cancer research and Myeloid leukemia. The studies in Clinical trial, Refractory, Disease and Chemotherapy under the umbrella field of Internal medicine overlap with concepts in In patient. The journal investigates Clinical trial research which frequently intersects with Intensive care medicine.
Most of the works presented in Therapeutic advances in hematology deals with Disease but it intersects with the subject of Bioinformatics. Multiple myeloma, Rituximab, Lymphoma, Pharmacology and Transplantation are some topics wherein Oncology research discussed in it have an impact. The work on Immunology tackled in the journal brings together disciplines like Haematopoiesis and Thrombopoietin.
Cancer research research featured in the journal incorporates concerns from various other topics such as Tyrosine kinase and Antibody. While Myeloid leukemia is the focus of it, it also provided insights into the studies of Myeloid, Myelodysplastic syndromes and Tyrosine-kinase inhibitor. In addition to Tyrosine-kinase inhibitor research, it aims to explore topics under Nilotinib and Imatinib.
The journal publications focus largely on the fields of Internal medicine, Myeloid leukemia, Oncology, Bioinformatics and Intensive care medicine. The most cited papers investigate Internal medicine research which frequently intersects with Gastroenterology. While work presented in the most cited publications provide substantial information on Oncology, it also covers topics in Janus kinase 2, Ruxolitinib, Clinical trial and Pharmacology.
Internal medicine, Oncology, Multiple myeloma, Lymphoma and In patient are the subjects of interest in the journal. Internal medicine research discussed connects with the study of Gastroenterology. It explores topics in Oncology which can be helpful for research in disciplines like Clinical trial, Newly diagnosed, Retrospective cohort study, Myeloid leukemia and Disease.
Cytarabine research are fields of study within Myeloid leukemia but they also intertwine with concepts in Reduced intensity. Therapeutic advances in hematology explores research in Multiple myeloma alongside concepts in Monoclonal antibody and other areas of study in Cancer research, Chimeric Antigen Receptor T-Cell Therapy and Antigen. Topics in Lymphoma explored in Therapeutic advances in hematology were investigated in conjunction with research in Follicular phase and Refractory.
A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.
The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.
The top authors publishing in Therapeutic advances in hematology (based on the number of publications) are:
The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.
Only papers with recognized affiliations are considered
The top affiliations publishing in Therapeutic advances in hematology (based on the number of publications) are:
The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.
The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.
The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.
During the most recent 2021 edition, 11.11% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 22.92% were posted by at least one author from the top 10 institutions publishing in the journal. Another 12.50% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 27.08% of all publications and 37.50% were from other institutions.
A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.
The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.
The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.
Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).
The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:
The chart below illustrates experience levels of first authors in cases of publications with multiple authors.
Aspiring hematologists and professionals looking for opportunities to explore topics covered in Therapeutic advances in hematology can pursue relevant academic programs to broaden their understanding. Numerous Universities and institutions offer programs tailored to internal medicine and oncology, which can be ideal for individuals looking to delve deeper into these fields.
The burgeoning field of Nursing, for instance, offers a vast selection of specialized programs including online courses for flexibility. These courses delve into areas such as anatomy, physiology, microbiology, and biostatistics, which constitute the foundation of understanding more complex subjects like oncology and myeloid leukemia. These programs not only provide students with a comprehensive understanding of the medical field, but also prepare them for careers in hospitals, clinics, and other healthcare settings.
You can find more information about these courses over here at the best online nursing programs in Alabama.
The impact of acquiring extensive education and skills can not be overlooked, especially when considering emerging trends and advances in hematology. By taking advantage of such opportunities, professionals can remain at the vanguard of medical innovations, and contribute more significantly to their respective fields of study. Whether you're interested in conducting in-depth clinical trials, researching on disease control and prevention, or focusing on specific branches of Oncology, there are programs designed to meet your needs.
Daniele Zama;Gianluca Bossù;Davide Leardini;Edoardo Muratore
(2020)Iman Abou Dalle;Elias Jabbour;Nicholas J. Short
(2020)Nichola Cooper;Ivy Altomare;Mark R. Thomas;Phillip L. R. Nicolson
(2021)Elisabetta Abruzzese;Michael Mauro;Jane Apperley;Ekaterina Chelysheva
(2020)Tania Jain;Mark R. Litzow
(2020)Beatrice Drexler;Jakob Passweg
(2021)Hubert Schrezenmeier;Austin Kulasekararaj;Lindsay Mitchell;Flore Sicre de Fontbrune
(2020)Ramzi Abboud;Jaebok Choi;Peter Ruminski;Mark A Schroeder
(2020)For those interested in expanding their knowledge and qualifications in the healthcare field, numerous online programs offer flexible pathways. For registered nurses aiming to advance their careers, rn to bsn online programs provide an excellent opportunity to earn a Bachelor of Science in Nursing without the need for additional clinical hours, making it a convenient option for working professionals.
For nurses seeking the highest level of clinical practice, exploring the shortest online dnp program can help accelerate the journey toward a Doctor of Nursing Practice degree without compromising educational quality.
Those new to healthcare or aiming for entry-level positions might consider medical assistant training, which often includes fast-track options that prepare students for essential supportive roles within a few weeks, providing a quick entry into healthcare employment.
Alternatively, for nurses who want a more manageable route toward a doctorate, researching the easiest dnp programs can reveal options that balance rigorous academics with flexible formats, making degree completion more achievable.
